Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)

This grant solicits applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology.

Funding: $400,000 total 

Duration: 3 years 

Research Authority due date: 10 days prior to submission

LOI (encouraged) due date: 28.1.18, 29.4.18,28.8.18

Full proposal due date: 28.2.18, 29.5.18, 28.9.18